ViriiSoma Pharmaceuticals

ViriiSoma Pharmaceuticals is the world's leading purveyor of biotechnology and Genetic manipulation. The company's corporate headquarters is located in Withmore City, Gold Sector, Soma Street at the Cobblestone Plaza. The towering glass tower contains both the administrative offices and research and development labs for the western hemisphere. Subsidiary company Ambrosia Pharmaceuticals is located in another building.

One of the greatest achievements of 2072 was ViriiSoma Pharmaceuticals releasing a treatment and cure for the Ebola-MX virus, agreeing to sell it to the UN at cost for treatment of people affected in the attacks.

Ten years later, and after heavy genetic research, ViriiSoma starts offering the combination of non-human genetic traits in the human body in 2082. Animal cosmetic modification has since become a world wide craze, and prolongs the UN's examination of human genetic manipulation.

In the aftermath of the Ferimid-Messisium Type K9 disease, which was fatal to dogs in 2106, ViriiSoma Pharmaceuticals bought RePet and immediately hiked up the prices after the merger.

Products

• a plethora of injectable enhancement products, ranging from heightened senses to increased disease prevention
• biomodification and manipulated or customized DNA, including non-human traits
• post-cloning treatments for DCD and disease management